Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
CRL [NYSE]
Charles River Laboratories International, Inc.
Index- P/E25.69 EPS (ttm)2.51 Insider Own1.70% Shs Outstand46.92M Perf Week0.86%
Market Cap3.03B Forward P/E17.97 EPS next Y3.59 Insider Trans-3.74% Shs Float46.05M Perf Month1.08%
Income119.60M PEG2.83 EPS next Q0.72 Inst Own99.70% Short Float4.45% Perf Quarter7.82%
Sales1.26B P/S2.41 EPS this Y2.40% Inst Trans-3.20% Short Ratio5.19 Perf Half Y20.29%
Book/sh14.57 P/B4.43 EPS next Y6.69% ROA6.80% Target Price65.47 Perf Year22.96%
Cash/sh3.10 P/C20.82 EPS next 5Y9.09% ROE17.70% 52W Range49.60 - 66.11 Perf YTD21.59%
Dividend- P/FCF17.78 EPS past 5Y17.90% ROI9.10% 52W High-1.75% Beta1.05
Dividend %- Quick Ratio1.80 Sales past 5Y-2.10% Gross Margin35.40% 52W Low30.95% ATR1.39
Employees7700 Current Ratio2.10 Sales Q/Q12.20% Oper. Margin16.30% RSI (14)57.85 Volatility2.20% 2.22%
OptionableYes Debt/Eq1.17 EPS Q/Q6.30% Profit Margin9.40% Rel Volume0.43 Prev Close64.49
ShortableYes LT Debt/Eq1.13 EarningsOct 29 AMC Payout0.00% Avg Volume394.48K Price64.95
Recom2.70 SMA201.58% SMA505.20% SMA20012.33% Volume139,433 Change0.71%
Feb-13-14Reiterated Barclays Equal Weight $41 → $55
Nov-21-13Initiated Deutsche Bank Hold $55
Sep-17-13Initiated UBS Neutral $49
Jun-03-13Reiterated Barclays Equal Weight $38 → $41
May-02-13Reiterated ISI Group Neutral $45.50 → $44.50
Feb-14-13Reiterated ISI Group Neutral $40.50 → $43
Jul-14-11Initiated BB&T Capital Mkts Buy $47
May-05-11Reiterated UBS Neutral $40 → $42
Jan-06-11Downgrade Deutsche Bank Buy → Hold $37 → $37
May-12-10Upgrade Robert W. Baird Neutral → Outperform $37
Jan-07-10Upgrade Deutsche Bank Hold → Buy $38.50 → $39
Nov-09-09Downgrade Barclays Capital Overweight → Equal Weight
May-13-09Initiated Deutsche Securities Hold
Apr-20-09Downgrade Jefferies & Co Buy → Hold $33
Feb-11-09Reiterated Jefferies & Co Buy $31 → $33
Feb-05-09Reiterated Barclays Capital Overweight $42 → $38
Jan-30-09Downgrade UBS Neutral → Sell
Jan-26-09Reiterated Jefferies & Co Buy $35 → $31
Jan-20-09Reiterated Barclays Capital Overweight $44 → $42
Nov-20-08Reiterated UBS Neutral $30 → $22
Nov-12-14 07:57AM  Intrexon (XON) Looks Good: Stock Moves 11% Higher Zacks
Nov-10-14 04:42PM  How Much to End a Marriage? Almost $1 Billion For Harold Hamm at Barrons.com
Nov-06-14 01:04PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials EDGAR Online Financials
Nov-04-14 06:03AM  Strength Seen in Covance (CVD): Stock Surges 25.9% Zacks
Nov-03-14 11:00AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Nov-01-14 08:07PM  10-Q for Charles River Laboratories International, Inc. Company Spotlight
Oct-30-14 08:11PM  Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong at TheStreet
07:49PM  Cramer Remix: Apologies owed on Wall Street at CNBC
02:52PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
11:30AM  Charles River (CRL) Beats on Q3 Earnings, Guidance Upped Zacks
09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today CCBN
Oct-29-14 06:45PM  Charles River beats Street 3Q forecasts AP
04:42PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
04:05PM  Charles River Laboratories Announces Third-Quarter 2014 Results from Continuing Operations Business Wire
02:15PM  Express Scripts Reports In-Line Q3 Earnings, Narrows View Zacks
11:00AM  McKesson Beats on Q2 Earnings, Revenues; Keeps Guidance Zacks
07:07AM  Q3 2014 Charles River Laboratories International Inc Earnings Release - After Market Close CCBN
Oct-28-14 07:16AM  Why Earnings Season Could Be Great for Charles River Laboratories International (CRL) Zacks
Oct-27-14 11:40AM  Omnicare Beats on Q3 Earnings and Sales, Outlook Positive Zacks
Oct-24-14 09:10AM  Healthways Earnings and Revenues in Line, View Maintained Zacks
Oct-08-14 04:15PM  Charles River Laboratories Schedules Third-Quarter 2014 Earnings Release and Conference Call Business Wire
Sep-09-14 09:08AM  Charles River (CRL) Stock: Moving Average Crossover Alert Zacks
Sep-08-14 08:00AM  Charles River Laboratories to Present at Morgan Stanley Global Healthcare Conference Business Wire
Sep-04-14 06:53AM  Why Intrexon (XON) Could Be Positioned for a Slump Zacks
Aug-27-14 06:55AM  iKang Healthcare Slumps: KANG Plunges 13.6% in Session Zacks
Aug-26-14 07:06AM  iKang Healthcare Group, Inc. (KANG) Jumps: Stock Surges 10.1% Zacks
Aug-18-14 06:54AM  Why Charles River Laboratories International (CRL) Could Beat Earnings Estimates Again Zacks
Aug-13-14 06:00AM  Jim Cramer's Top Stock Picks: TSLA TNET CRL at TheStreet
Aug-12-14 08:13PM  Jim Cramer's 'Mad Money' Recap: Stocks That Stand the Test of Time at TheStreet
06:50PM  Cramer: Is Charles River getting ready to run? at CNBC
Aug-08-14 07:30AM  Charles River Laboratories (CRL) Jumps: Stock Moves 5% Higher Zacks
Aug-07-14 01:10PM  Charles River Beats on Q2 Earnings & Revenues, Outlook Upped Zacks +5.04%
09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today CCBN
06:02AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
Aug-06-14 04:40PM  Charles River Laboratories Announces Second-Quarter 2014 Results from Continuing Operations Business Wire
07:07AM  Q2 2014 Charles River Laboratories International, Inc. Earnings Release - After Market Close CCBN
Jul-24-14 09:00AM  Charles River Laboratories to Webcast Investor Meeting Business Wire
Jul-22-14 04:51PM  John Rogers' Ariel Fund Second Quarter 2014 Commentary Gurufocus
Jul-07-14 04:15PM  Charles River Laboratories Schedules Second-Quarter 2014 Earnings Release and Conference Call Business Wire
Jun-05-14 10:30AM  Insider Trading Alert - FWLT, CRL And SAH Traded By Insiders at TheStreet
Jun-02-14 09:33AM  Charles River Laboratories to Present at Jefferies and William Blair Conferences Business Wire
May-20-14 09:37AM  UPDATE: Morgan Stanley Reiterates On Charles River Laboratories Following CEO Conference Call Benzinga
May-12-14 11:29AM  [video] Jim Cramer Says Yahoo Should Buy Yelp With Its Alibaba Payday at TheStreet
May-09-14 12:43PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
May-05-14 04:59PM  Charles River Laboratories to Present at Bairds Growth Stock Conference Business Wire
May-02-14 08:50AM  Charles River Laboratories (CRL) is now in Oversold Territory Zacks
May-01-14 03:41PM  Charles River, PAREXEL lower after peers combine at theflyonthewall.com
02:36PM  Charles River Beats on Earnings, Guidance Upped Zacks
09:00AM  Charles River Laboratories International, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
Apr-30-14 04:49PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
04:44PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04:30PM  Charles River Laboratories Announces First-Quarter 2014 Results from Continuing Operations Business Wire
10:50AM  Express Scripts Misses Earnings, Guides Low Zacks
07:07AM  Q1 2014 Charles River Laboratories International, Inc. Earnings Release - After Market Close CCBN
06:55AM  Is Charles River Laboratories (CRL) Stock a Solid Choice Right Now? Zacks
Apr-29-14 03:26PM  Charles River Laboratories: A Well-Positioned CRO Due To Blossom In Pre-Clinical Services at Seeking Alpha
Apr-07-14 04:15PM  Charles River Laboratories Schedules First-Quarter 2014 Earnings Release and Conference Call Business Wire
Apr-04-14 01:00PM  Must-know catalysts and valuation for ICON Market Realist -5.97%
11:43AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, EDGAR Online
09:00AM  Why analyst expectation of a margin compression is unreasonable Market Realist
Apr-03-14 04:22PM  Market overview for CROs suggest healthy growth for ICON Market Realist
Apr-01-14 01:35AM  Charles River Laboratories and Galapagos complete transaction GlobeNewswire
01:32AM  Charles River Laboratories and Galapagos complete transaction Thomson Reuters ONE
Mar-31-14 08:48PM  Charles River Laboratories Completes the Acquisition of the CRO Services Division of Galapagos NV Business Wire
Mar-19-14 06:00AM  Jim Cramer's Top Stock Picks: CRL TSLA EOG at TheStreet
Mar-18-14 08:07PM  Jim Cramer's 'Mad Money' Recap: Profits Still Matter at TheStreet
06:16PM  Cramer's single stock for those baffled by biotech at CNBC
06:15PM  [video] Charles River CEO: Critical to drug development process at CNBC
Mar-17-14 04:46PM  Charles River Laboratories International Larger Than S&P 500 Component Cliffs Natural Resources at TheStreet
Mar-14-14 06:30PM  Best States, Worst States For Dividend Lovers at Forbes
04:40PM  Charles River Acquires CRO Division of Galapagos Zacks
Mar-13-14 11:39AM  Charles River Aims To Be 'One-Stop Shop' With Buyout Optionetics
09:00AM  Charles River Laboratories to Acquire the CRO Services Division of Galapagos NV Call scheduled for 9:00 am ET today CCBN
05:00AM  Galapagos NV BioFocus Service Operations Acquired by Charles River Laboratories Call scheduled for 5:00 am ET today CCBN
03:18AM  Charles River to buy Galapagos drug service operations Reuters
02:47AM  Charles River Laboratories to acquire Galapagos' Argenta and BioFocus service operations for up to 134 million Thomson Reuters ONE
02:45AM  Charles River Laboratories to Acquire the CRO Services Division of Galapagos NV Business Wire
Mar-10-14 01:00PM  Insider Trading Alert - ETN, PCG And CRL Traded By Insiders Optionetics
Mar-03-14 08:30AM  Charles River Laboratories to Present at Cowen and Raymond James Conferences Business Wire
Feb-28-14 10:45AM  Insider Trading Alert - CRL, IDA And DAL Traded By Insiders at TheStreet
Feb-25-14 05:23PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-K, Annual Report EDGAR Online
Feb-12-14 03:34PM  Charles River Laboratories' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
09:15AM  Charles River Beats Earnings Estimates in Q4 Zacks
08:30AM  Taylor Morrison Home Corp Earnings Call scheduled for 8:30 am ET today CCBN
06:03AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
Feb-11-14 04:30PM  Charles River Laboratories Announces Fourth-Quarter and Full-Year 2013 Results from Continuing Operations and Provides 2014 Guidance Business Wire
07:07AM  Q4 2013 Charles River Laboratories International, Inc. Earnings Release - After Market Close CCBN
Feb-10-14 12:19PM  The market in a minute: Sentiment reboot at MarketWatch
11:50AM  Will Zoetis (ZTS) Miss Estimates in Q4? Zacks
Feb-04-14 05:53PM  Late-stage drug research powers Covance profit beat Reuters
Jan-27-14 04:15PM  Charles River Laboratories Schedules Fourth-Quarter 2013 Earnings and 2014 Guidance Release and Conference Call Business Wire
Jan-13-14 08:00AM  Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Business Wire
Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. It operates through two segments, Research Models and Services (RMS), and Preclinical Services (PCS). The RMS segment produces and sells research model strains, principally genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist customers in the drug discovery and development process, which include genetically engineered models and services, insourcing solutions, discovery research services, and research animal diagnostic services; endotoxin and microbial detection products and services; and avian vaccine products and services. The PCS segment provides preclinical services, including in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. This segment offers services in the areas of bioanalysis, pharmacokinetics, and drug metabolism; toxicology; and pathology services, as well as testing of biologics and devices frequently outsourced by pharmaceutical and biotechnology companies. The company serves pharmaceutical companies, biotechnology companies, government agencies, hospitals, and academic institutions worldwide. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GELLER JORGCorporate Executive VPNov 14Option Exercise58.587,350430,56355,679Nov 17 02:42 PM
GELLER JORGCorporate Executive VPNov 14Sale63.801,740111,01348,329Nov 17 02:44 PM
GELLER JORGCorporate Executive VPNov 14Sale63.575,610356,61950,069Nov 17 02:42 PM
Molho DavideCorporate Executive VPNov 12Option Exercise37.039,360346,60152,664Nov 14 03:14 PM
Molho DavideCorporate Executive VPNov 12Sale64.689,360605,37343,304Nov 14 03:14 PM
REESE C RICHARDDirectorNov 06Option Exercise61.726,000370,32028,790Nov 07 02:20 PM
REESE C RICHARDDirectorNov 06Sale63.395,849370,74322,941Nov 07 02:20 PM
Crowley John JSVP, Chief Accounting OfficerNov 04Option Exercise46.621,00046,6205,607Nov 05 02:37 PM
Crowley John JSVP, Chief Accounting OfficerNov 04Sale64.001,00064,0014,607Nov 05 02:37 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 03Option Exercise52.8636,1001,908,138140,311Nov 04 02:17 PM
Molho DavideCorporate Executive VPNov 03Option Exercise37.0316,402607,36659,706Nov 04 03:24 PM
GILLETT NANCYCorporate Executive VPNov 03Option Exercise58.5826,7311,565,90256,646Nov 05 12:19 PM
MASSARO GEORGEDirectorNov 03Option Exercise41.6716,710696,33226,220Nov 04 03:33 PM
MASSARO GEORGEDirectorNov 03Sale65.0016,7101,086,15015,510Nov 04 03:33 PM
GILLETT NANCYCorporate Executive VPNov 03Sale64.9135,3312,293,16329,915Nov 05 12:19 PM
Molho DavideCorporate Executive VPNov 03Sale64.5416,4021,058,54743,304Nov 04 03:24 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 03Sale65.0036,1002,346,500104,211Nov 04 02:17 PM
GILLETT NANCYCorporate Executive VPOct 30Option Exercise58.581,06962,62239,584Nov 03 10:47 AM
GILLETT NANCYCorporate Executive VPOct 30Sale65.001,06969,48538,515Nov 03 10:47 AM
JOHST DAVID PCorp Executive VPOct 28Option Exercise42.2574,7803,159,360217,729Oct 30 05:04 PM
JOHST DAVID PCorp Executive VPOct 28Sale64.0074,7804,785,920142,949Oct 30 05:04 PM
FOSTER JAMES CChairman, President and CEOOct 21Option Exercise47.7528,9971,384,607379,961Oct 22 01:26 PM
FOSTER JAMES CChairman, President and CEOOct 21Sale62.0028,9971,797,814350,964Oct 22 01:26 PM
FOSTER JAMES CChairman, President and CEOOct 03Option Exercise47.68136,6476,515,753487,611Oct 07 02:10 PM
GELLER JORGCorporate Executive VPOct 03Sale61.6089355,00748,329Oct 06 12:44 PM
FOSTER JAMES CChairman, President and CEOOct 03Sale62.00136,6478,472,114350,964Oct 07 02:10 PM
Molho DavideCorporate Executive VPSep 04Option Exercise58.584,900287,04248,204Sep 05 11:24 AM
Molho DavideCorporate Executive VPSep 04Sale61.344,900300,57143,304Sep 05 11:24 AM
MASSARO GEORGEDirectorAug 26Option Exercise28.2910,440295,34826,950Aug 27 03:30 PM
MASSARO GEORGEDirectorAug 26Sale60.0010,440626,40016,510Aug 27 03:30 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOAug 18Option Exercise47.6544,6492,127,419148,860Aug 19 03:23 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOAug 18Sale59.3821,4931,276,172104,211Aug 19 03:24 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOAug 18Sale59.2523,1561,372,053125,704Aug 19 03:23 PM
WALLMAN RICHARD FDirectorAug 12Sale58.203,240188,56816,180Aug 13 01:17 PM
CHUBB STEPHEN DDirectorJun 02Sale52.932,000105,85524,365Jun 04 07:06 AM
Kochevar Deborah TurnerDirectorMay 22Option Exercise43.394,030174,86220,620May 23 09:41 AM
Kochevar Deborah TurnerDirectorMay 22Sale53.156,150326,88414,470May 23 09:41 AM
MASSARO GEORGEDirectorMay 09Option Exercise50.4025012,60016,760May 12 02:46 PM
MASSARO GEORGEDirectorMay 09Sale52.4625013,11416,510May 12 02:46 PM
MASSARO GEORGEDirectorMay 08Sale52.701,62085,36716,510May 09 04:55 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOMay 05Option Exercise24.8015,000372,000119,211May 06 03:00 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOMay 05Sale51.119,070463,564104,711May 06 03:07 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOMay 05Sale51.3650025,679104,211May 06 03:08 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOMay 05Sale50.765,430275,620113,781May 06 03:00 PM
Molho DavideCorporate Executive VPMar 07Option Exercise37.9229,5001,118,64072,804Mar 11 01:04 PM
Molho DavideCorporate Executive VPMar 07Sale57.311,70097,43343,304Mar 11 01:07 PM
Molho DavideCorporate Executive VPMar 07Sale57.2527,8001,591,44345,004Mar 11 01:04 PM
GILLETT NANCYCorporate Executive VPMar 07Sale57.351106,30938,515Mar 07 12:58 PM
GILLETT NANCYCorporate Executive VPMar 06Sale58.3710,000583,66338,625Mar 07 12:58 PM
GILLETT NANCYCorporate Executive VPMar 04Option Exercise37.5013,650511,87962,275Mar 06 01:46 PM
GILLETT NANCYCorporate Executive VPMar 04Sale58.9813,650805,03448,625Mar 06 01:46 PM
CHUBB STEPHEN DDirectorMar 03Sale58.702,000117,40023,645Mar 05 10:29 AM
GILLETT NANCYCorporate Executive VPFeb 28Option Exercise38.3211,040423,03354,202Mar 04 04:00 PM
GELLER JORGCorporate Executive VPFeb 28Option Exercise37.8919,515739,43768,737Mar 03 06:09 PM
GELLER JORGCorporate Executive VPFeb 28Sale60.036,500390,16349,222Mar 03 06:14 PM
GELLER JORGCorporate Executive VPFeb 28Sale59.417,486444,74755,722Mar 03 06:12 PM
GELLER JORGCorporate Executive VPFeb 28Sale59.065,529326,52063,208Mar 03 06:09 PM
GILLETT NANCYCorporate Executive VPFeb 28Sale60.0781348,84143,162Mar 04 04:03 PM
GILLETT NANCYCorporate Executive VPFeb 28Sale59.615,727341,37943,975Mar 04 04:01 PM
GILLETT NANCYCorporate Executive VPFeb 28Sale59.114,500265,99849,702Mar 04 04:00 PM
GELLER JORGCorporate Executive VPFeb 27Sale59.9458234,88549,222Mar 03 09:25 AM
GILLETT NANCYCorporate Executive VPFeb 27Sale60.004,000240,00043,162Feb 28 11:32 AM
FOSTER JAMES CChairman, President and CEOFeb 26Option Exercise37.9240,0001,516,800380,258Feb 28 05:03 PM
FOSTER JAMES CChairman, President and CEOFeb 26Sale58.8422,8441,344,105347,360Feb 28 05:05 PM
FOSTER JAMES CChairman, President and CEOFeb 26Sale58.926,702394,882340,258Feb 28 05:06 PM
FOSTER JAMES CChairman, President and CEOFeb 26Sale58.5610,454612,214369,804Feb 28 05:03 PM
GELLER JORGCorporate Executive VPFeb 26Sale58.7843125,33549,804Feb 28 10:11 AM
GELLER JORGCorporate Executive VPFeb 25Sale58.493,188186,46050,235Feb 27 10:13 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale58.5520,2431,185,293350,298Feb 27 04:38 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale58.734,954290,951345,344Feb 27 04:39 PM
FOSTER JAMES CChairman, President and CEOFeb 24Option Exercise38.2146,1671,763,937402,008Feb 26 05:03 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale59.1212,027710,999345,344Feb 26 05:07 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale58.9117,0001,001,547357,371Feb 26 05:05 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale58.7417,1401,006,872374,371Feb 26 05:03 PM
GELLER JORGCorporate Executive VPFeb 24Sale58.8876945,28053,423Feb 26 09:17 AM
GILLETT NANCYCorporate Executive VPFeb 20Sale58.964,000235,83550,510Feb 24 09:18 AM
CHUBB STEPHEN DDirectorFeb 19Option Exercise50.406,000302,40030,843Feb 21 12:26 PM
CHUBB STEPHEN DDirectorFeb 19Sale58.355,198303,27825,645Feb 21 12:26 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 18Option Exercise24.8015,000372,000119,539Feb 20 02:23 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 18Sale58.351,00058,346104,039Feb 20 02:34 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 18Sale58.351,00058,346104,039Feb 20 02:30 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 18Sale58.351,00058,346104,039Feb 20 02:25 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 18Sale58.0514,000812,661105,539Feb 20 02:23 PM
MILNE GEORGE M JRDirectorFeb 13Option Exercise50.406,000302,40034,070Feb 18 09:59 AM
MILNE GEORGE M JRDirectorFeb 13Sale58.556,000351,28928,070Feb 18 09:59 AM
JOHST DAVID PCorp Executive VPJan 13Option Exercise37.0319,750731,343161,549Jan 14 03:27 PM
JOHST DAVID PCorp Executive VPJan 13Sale58.0019,7501,145,500141,799Jan 14 03:27 PM
MASSARO GEORGEDirectorJan 07Option Exercise50.405,750289,80021,160Jan 09 09:12 AM
MASSARO GEORGEDirectorJan 07Sale54.005,750310,50015,410Jan 09 09:12 AM
ACKERMAN THOMAS FCorp. Executive VP & CFODec 20Option Exercise24.808,150202,120112,689Dec 24 10:01 AM
ACKERMAN THOMAS FCorp. Executive VP & CFODec 20Sale52.983,150166,889104,539Dec 24 10:03 AM
ACKERMAN THOMAS FCorp. Executive VP & CFODec 20Sale52.725,000263,615107,689Dec 24 10:01 AM
GELLER JORGCorporate Executive VPDec 04Option Exercise46.607,200335,52061,392Dec 06 12:10 PM
GELLER JORGCorporate Executive VPDec 04Sale51.937,200373,93054,192Dec 06 12:10 PM
CHUBB STEPHEN DDirectorDec 02Sale51.922,000103,83726,843Dec 03 11:31 AM